Literature DB >> 10810713

Chiral catalyst optimization using both solid-phase and liquid-phase methods in asymmetric aza Diels-Alder reactions

.   

Abstract

[formula: see text] In the presence of 1-5 mol % of a chiral zirconium catalyst, aza Diels-Alder reactions of aldimines with Danishefsky's dienes proceeded smoothly to afford the corresponding piperidine derivatives in high yields with high enantioselectivities. For the catalyst optimization, solid-phase and liquid-phase methods were successfully used. In the solid-phase approach, polymer-supported (R)-1,1'-binaphthols (BINOLs) have been synthesized and rapid optimization using the solid-phase reactions has been achieved. On the other hand, novel chiral zirconium cyanides were developed as excellent catalysts using the liquid-phase approach.

Entities:  

Year:  2000        PMID: 10810713     DOI: 10.1021/ol005656b

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Air-stable, storable, and highly efficient chiral zirconium catalysts for enantioselective Mannich-type, aza Diels-Alder, aldol, and hetero Diels-Alder reactions.

Authors:  Shu Kobayashi; Masaharu Ueno; Susumu Saito; Yumiko Mizuki; Haruro Ishitani; Yasuhiro Yamashita
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-05       Impact factor: 11.205

2.  Asymmetric aza-Diels-Alder reaction of Danishefsky's diene with imines in a chiral reaction medium.

Authors:  Bruce Pégot; Van Buu Olivier Nguyen; Didier Gori; Giang Vo-Thanh
Journal:  Beilstein J Org Chem       Date:  2006-09-18       Impact factor: 2.883

Review 3.  Recent Advances in Zirconium-89 Chelator Development.

Authors:  Nikunj B Bhatt; Darpan N Pandya; Thaddeus J Wadas
Journal:  Molecules       Date:  2018-03-12       Impact factor: 4.411

4.  Asymmetric Brønsted acid-catalyzed aza-Diels-Alder reaction of cyclic C-acylimines with cyclopentadiene.

Authors:  Magnus Rueping; Sadiya Raja
Journal:  Beilstein J Org Chem       Date:  2012-10-23       Impact factor: 2.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.